 |
John Kurhanewicz, PhD
Biographical Sketch
| BS, 1982, New College, Sarasota,
FL, Chemistry |
| PhD, 1987, University of South
Florida, Tampa, FL, Chemistry |
| Post-doctorate, 1990, University of California,
San Francisco, in vivo Spectroscopy |
| |
|
| 1993-2000 |
Assistant Professor, Department of Radiology and Pharmaceutical
Chemistry, University of California, San Francisco |
| 2000-2006 |
Associate Professor, Department of Radiology and
Pharmaceutical Chemistry, University of California, San
Francisco |
| 2006-Present |
Professor, Department of Radiology and Biomedical Imaging,
and Pharmaceutical Chemistry, University of California,
San Francisco
|
| 2007-Present |
Professor of Urology, University of California, San
Francisco |
John Kurhanewicz, PhD, who has been UCSF faculty
in the Departments of Radiology and Biomedical Imaging, and
Pharmaceutical Chemistry since 1993, joined the UCSF Department
of Urology with a joint appointment in 2007. He is a member of
the California Institute for Quantitative Biology, the UCSF Comprehensive
Cancer Center, and the UCSF-UC Berkeley Bioengineering Graduate
Group. Kurhanewicz serves on grant review panels for the National
Cancer Institutes, National Institute of Health, American Cancer
Society and the Department of Defense. He has served as scientific
reviewer for over 20 different journals and has been a major
contributor,
with his courses in molecular and advanced imaging in oncology,
to meetings of the International Society of Magnetic Resonance
in Medicine and Radiologic Society of North America.
Kurhanewicz
is recognized internationally for his research in magnetic resonance
imaging (MRI) and spectroscopic imaging (MRSI) of patients with
prostate cancer and was involved in the development and translation
of this technology into the clinic. He is Director of the UCSF
Prostate Imaging Program and the Hyperpolarized High Field NMR
Facility For Metabolic Profiling of Human Disease. Kurhanewicz
has been awarded major grants for the development and application
of MR metabolic imaging to prostate cancer patients and biomarker
development. His other areas of research include:
spectroscopy (13C and 31P), diffusion and perfusion imaging of
prostate cancer on high field MR scanners; the identification
of new biomarkers using a combination of ex vivo HR-MAS
spectroscopy, pathology and gene expression of tissue samples
and bio-fluids.
return
to top
|
|
|
|
|
|
